Infección por Helicobacter pylori, causas síntomas y tratamiento

Yimy Alfredo Nazareno Valencia, Lenin Saulo Verduga Mena, Mario Alberto Patiño Aquin, Jeannina Elizabeth Sánchez Gómez

Resumen


En el presente artículo, se hace una revisión sobre los aspectos básicos del tratamiento de Helicobacter pylori, destacando las causas de la falla del tratamiento y se dan estrategias para optimizar el tratamiento de acuerdo a la mejor evidencia publicada. Se destaca la resistencia a los antimicrobianos como la principal causa de fracaso terapéutico, así como también los diferentes compartimentos donde se aloja el microrganismo. Se muestran los principales esquemas actualmente disponibles y la forma de elegir las terapias de primera, segunda, tercera línea y terapias de rescate.

Palabras clave


Helicobacter; Resistencia a medicamentos; Inhibidores de bomba de protones.

Texto completo:

PDF HTML XML

Referencias


Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-9.

O´Coonor A, O´Morain CA, Ford CA. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol. 2017;14(4):230-240.

Malfertheiner P, Megraud F, O´Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Mangement of Helicobacter pylori infection:The Maastricht V/Florence Consensus Report. Gut 2017;66(1):6-30.

Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212-39.

Fallone CA, Chiba N, van Zanten SV. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016;151(1):51-69.

Gisbert JP, Molina-Infante J, Amador J, Bermejo F, Bujanda L, Calvet X, et al. IV conferencia española de consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterol Hepatol. 2016;39(10):697-721.

Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353-67.

IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer [Internet]. Lyon, France: International Agency for Research on Cancer; 2014 [citado el 7 de julio de 2017]. Disponible en: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/ index.php. [ Links ]

Nam JH, Hong CW, Kim BC, Shin A, Ryu KH, Park BJ, et al. Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms. Cancer Causes Control. 2017;28(2):107-15. [ Links ]

Rokkas T, Gisbert JP, Niv Y, O'Morain C. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United European Gastroenterol J. 2015;3(6):539-50. [ Links ]

Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta- analysis. Clin Gastroenterol Hepatol. 2007;5(12):1413-7. [ Links ]

Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology. 2001;121(5):1120-6. [ Links ]

Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2012;47(2):129-35.

Neumeister P, Troppan K, Raderer M. Management of gastric mucosa-associated lymphoid tissue lymphoma. Dig Dis. 2015;33(1):11-8.

Scott D, Weeks D, Melchers K. The life and death of Helicobacter pylori. Gut 1998;43(Suppl 1):S56-S60.

Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008;5(6):321-31.

Yonezawa H, Osaki T, Kamiya S. Biofilm Formation by Helicobacter pylori and its involvement for antibiotic resistance. Biomed Res Int. 2015;2015:914791.

Wang YH, LV ZF, Zhong Y, Liu DS, Chen SP, Xie Y. The internalization of Helicobacter pylori plays a role in the failure of H. pylori eradication. Helicobacter. 2017;22(1):e12324.

Malfertheiner P, Selgrad M. Helicobacter pylori. Curr Opin Gastroenterol. 2014;30(6):589-95.

Gisbert JP, McNicholl AG. Optimization strategies aimed to increase the efficacy of H.pylori eradication therapies. Helicobacter. 2017;22(4):e12392.

Graham DY, Dore MP. Helicobacter pyloritherapy: a paradigm shift. Expert Rev Anti Infect Ther. 2016;14(6):577-85.

Shiotani A, Lu H, Dore MP, Graham DY. Treating Helicobacter pylori effectively while minimizing misuse of antibiotics. Clev Clin J Med. 2017;84(4):310-8.

Villoria A, García P, Calvet X, Gisbert J, Vergara M. Metaanalysis: high dose proton pump inhibtor vs standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2008;28(7):868-77.

Ducoumau A, Bénéjat L, Sifré LE, Lehours P, Mégraud F. Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods. Clin Microbiol Infect. 2016;22(8):715-8.

Thung I, Aramin RH, Vavinskaya V, Gupta S, Park JY, Crowe SE, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514-33.

Camargo MC, García A, Riquelme A, Otero W, Camargo CA, Hernández-García T, et al. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin Am J Gastroenterol. 2014;109(4):485-95.

Gisbert JP, Calvet X. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther. 2012;35(2):209-21.

Furuta T, Graham DY. Pharmacologic aspects of eradicaction therapy for Helicobacterpylori infection. Gastroenterol Clin North Am. 2010;39(3):465-80.




DOI: http://dx.doi.org/10.23857/dc.v7i6.2393

Métricas del Artículos

Cargando Métricas.....

Metrics powered by MI WEB PRO

Enlaces de Referencia

  • Por el momento, no existen enlaces de referencia


Copyright (c) 2021 Yimy Alfredo Nazareno Valencia, Lenin Saulo Verduga Mena, Mario Alberto Patiño Aquin, Jeannina Elizabeth Sánchez Gómez

URL de la Licencia: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es

Polo de Capacitación, Investigación y Publicación (POCAIP)

Dirección: Ciudadela El Palmar, II Etapa,  Manta - Manabí - Ecuador.

Código Postal: 130801

Teléfonos: 056051775/0991871420

Email: [email protected]

URL: https://www.dominiodelasciencias.com/

DOI: https://doi.org/10.23857/pocaip